| Original language | English (US) |
|---|---|
| Pages (from-to) | 479-481 |
| Number of pages | 3 |
| Journal | Current Opinion in Lipidology |
| Volume | 18 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2007 |
Fingerprint
Azetidines
Metabolic Syndrome X
Biological Models
Hypercholesterolemia
LDL Cholesterol
Atherosclerosis
Acquired Immunodeficiency Syndrome
Obesity
Clinical Trials
Therapeutics
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
Cite this
Jialal, I., & Devaraj, S. (2007). Therapy and clinical trials. Current Opinion in Lipidology, 18(4), 479-481. https://doi.org/10.1097/MOL.0b013e32823bcb39
Therapy and clinical trials. / Jialal, Ishwarlal; Devaraj, Sridevi.
In: Current Opinion in Lipidology, Vol. 18, No. 4, 08.2007, p. 479-481.Research output: Contribution to journal › Article
Jialal, I & Devaraj, S 2007, 'Therapy and clinical trials', Current Opinion in Lipidology, vol. 18, no. 4, pp. 479-481. https://doi.org/10.1097/MOL.0b013e32823bcb39
Jialal I, Devaraj S. Therapy and clinical trials. Current Opinion in Lipidology. 2007 Aug;18(4):479-481. https://doi.org/10.1097/MOL.0b013e32823bcb39
@article{2499f6c0df49453db1484baa34c72ce8,
title = "Therapy and clinical trials",
author = "Ishwarlal Jialal and Sridevi Devaraj",
year = "2007",
month = "8",
doi = "10.1097/MOL.0b013e32823bcb39",
language = "English (US)",
volume = "18",
pages = "479--481",
journal = "Current Opinion in Lipidology",
issn = "0957-9672",
publisher = "Lippincott Williams and Wilkins",
number = "4",
}
TY - JOUR
T1 - Therapy and clinical trials
AU - Jialal, Ishwarlal
AU - Devaraj, Sridevi
PY - 2007/8
Y1 - 2007/8
UR - http://www.scopus.com/inward/record.url?scp=34447320191&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34447320191&partnerID=8YFLogxK
U2 - 10.1097/MOL.0b013e32823bcb39
DO - 10.1097/MOL.0b013e32823bcb39
M3 - Article
C2 - 17620868
AN - SCOPUS:34447320191
VL - 18
SP - 479
EP - 481
JO - Current Opinion in Lipidology
JF - Current Opinion in Lipidology
SN - 0957-9672
IS - 4
ER -